| CXorf9 |
IPI00004504 |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.295 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
CRLF3 |
IPI00295387 |
0.295 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.295 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
0.295 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
CD28 |
CD28: T-cell-specific surface glycoprotein CD28 precursor |
0.295 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
CD7 |
CD7: T-cell antigen CD7 precursor |
0.295 |
Evidence |
|
| MYCBP2 |
MYCBP2, KIAA0916, PAM: Probable E3 ubiquitin-protein ligase MYCBP2 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
0.295 |
Evidence |
|
| ADAM23 |
ADAM23, MDC3: ADAM 23 precursor |
TLN2 |
TLN2: Uncharacterized protein TLN2 |
0.295 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
0.295 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
0.295 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
0.295 |
Evidence |
|
| EIF5B |
EIF5B, IF2, KIAA0741: Eukaryotic translation initiation factor 5B |
NBN |
NBN, NBS, NBS1, P95: Nibrin |
0.295 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CRLF3 |
IPI00295387 |
0.295 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
0.295 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
0.295 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
0.295 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
0.295 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PLEK |
PLEK, P47: Pleckstrin |
0.295 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
0.295 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
0.295 |
Evidence |
|
| TLR2 |
TLR2, TIL4: Toll-like receptor 2 precursor |
IL8 |
IL8: Interleukin-8 precursor |
0.295 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
IPO7 |
IPO7: Uncharacterized protein IPO7 |
0.295 |
Evidence |
|
| PPL |
PPL, KIAA0568: Periplakin |
PKP3 |
PKP3: Plakophilin-3 |
0.295 |
Evidence |
|
| PPL |
PPL, KIAA0568: Periplakin |
JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
0.295 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.295 |
Evidence |
|